{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:58:28Z","timestamp":1777550308763,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.cbi.2013.12.010","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T03:53:21Z","timestamp":1388721201000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques"],"prefix":"10.1016","volume":"210","author":[{"given":"Yvonne J.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Gearhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Segundo","family":"Hernandez-Abanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2013.12.010_b0005","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1021\/bi982678l","article-title":"Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level","volume":"38","author":"Millard","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2013.12.010_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-2797(99)00017-4","article-title":"A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate","volume":"119\u2013120","author":"Rosenberry","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2013.12.010_b0015","series-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"239","article-title":"Anticholinesterase Agents","author":"Taylor","year":"2010"},{"key":"10.1016\/j.cbi.2013.12.010_b0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1081\/CLT-200026967","article-title":"The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning","volume":"42","author":"Guven","year":"2004","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.cbi.2013.12.010_b0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<298::AID-DDR13>3.0.CO;2-X","article-title":"Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs","volume":"50","author":"Ashani","year":"2000","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cbi.2013.12.010_b0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cbi.2005.10.025","article-title":"Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys","volume":"157","author":"Lenz","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2013.12.010_b0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bcp.2010.09.007","article-title":"Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX","volume":"81","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2013.12.010_b0040","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bcp.2011.09.019","article-title":"Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Gottingen minipigs exposed to sarin vapor","volume":"82","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2013.12.010_b0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cbi.2010.02.042","article-title":"Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model","volume":"187","author":"Rosenberg","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2013.12.010_b0050","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1073\/pnas.0702756104","article-title":"Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2013.12.010_b0055","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1073\/pnas.1009021107","article-title":"Plant-derived human butyrylcholinesterase but not an organophosphorous-compound hydrolyzing variant thereof protects rodents against nerve agents","volume":"107","author":"Geyer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2013.12.010_b0060","doi-asserted-by":"crossref","DOI":"10.5772\/29014","article-title":"Development of a prophylactic butyrylcholinesterase bioscavenger to protect against insecticide toxicity using a homologous macaque model","author":"Rosenberg","year":"2012"},{"key":"10.1016\/j.cbi.2013.12.010_b0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cbi.2005.10.013","article-title":"Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase","volume":"157\u2013158","author":"Chilukuri","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2013.12.010_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0024-3205(02)02203-8","article-title":"Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase","volume":"72","author":"Rosenberg","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2013.12.010_b0075","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1126\/science.156.3783.1748","article-title":"Cholinesterase in plasma: first reported absence in the Bantu; half-life determination","volume":"156","author":"Jenkins","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.cbi.2013.12.010_b0080","first-page":"337","article-title":"Use of serum cholinesterases in severe organophosphorus poisoning. Our experience","volume":"54","author":"Cascio","year":"1988","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.cbi.2013.12.010_b0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cbi.2012.11.004","article-title":"Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques","volume":"203","author":"Rosenberg","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"Suppl. 11","key":"10.1016\/j.cbi.2013.12.010_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1289\/ehp.94102s1151","article-title":"Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters","volume":"102","author":"Gearhart","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2013.12.010_b0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuro.2004.03.002","article-title":"Physiologically based pharmacokinetic\/pharmacodynamic model for the organophosphorus pesticide diazinon","volume":"25","author":"Poet","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2013.12.010_b0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.cbi.2013.12.010_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/dta.381","article-title":"Organophosphorus hydrolase as an in vivo catalytic nerve agent bioscavenger","volume":"4","author":"Wales","year":"2012","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.cbi.2013.12.010_b0110","unstructured":"E.S. Levine, Nerve agent simulants: can they be used as substitutes for nerve agents in biomedical research? Prepared for the U.S. Army Medical Research Institute of Chemical Defense under, Contract No. GS-23F-8006H, 2006."},{"key":"10.1016\/j.cbi.2013.12.010_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/taap.1996.0003","article-title":"Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat","volume":"136","author":"Milatovic","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2013.12.010_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tox.2006.12.006","article-title":"Toxic doses of paraoxon alter the respiratory pattern without causing respiratory failure in rats","volume":"232","author":"Villa","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2013.12.010_b0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0272-0590(90)90293-S","article-title":"Acute inhalation toxicity of soman and sarin in baboons","volume":"14","author":"Anzueto","year":"1990","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2013.12.010_b0130","series-title":"Inhaled GB Retention Studies in Man at Rest and During Activity","author":"Oberst","year":"1959"},{"key":"10.1016\/j.cbi.2013.12.010_b0135","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00204-006-0120-2","article-title":"Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?","volume":"80","author":"Maxwell","year":"2006","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.cbi.2013.12.010_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002040050580","article-title":"Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics","volume":"73","author":"Worek","year":"1999","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2013.12.010_b0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-2952(98)00035-5","article-title":"Inhibition of acetylcholinesterase and butyryl-cholinesterase by chlorpyrifos-oxon","volume":"56","author":"Amitai","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2013.12.010_b0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tox.2008.03.013","article-title":"An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX","volume":"248","author":"Dorandeu","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2013.12.010_b0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/c2tx20009k","article-title":"Induction of plasma acetylcholinesterase activity and apoptosis in mice treated with the organophosphate toxicant, tri-o-cresyl phosphate","volume":"1","author":"Jiang","year":"2012","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.cbi.2013.12.010_b0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/08958370600602116","article-title":"Butyrcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX","volume":"18","author":"Graham","year":"2006","journal-title":"Inhalation Toxicol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713003499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713003499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:31:22Z","timestamp":1757856682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279713003499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":32,"alternative-id":["S0009279713003499"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2013.12.010","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2013.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}